Trials / Completed
CompletedNCT05753033
The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers
A Phase I Bridging Study to Evaluate the PK, Safety and Tolerability of SR750 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Shanghai SIMR Biotechnology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, double-blind, placebo-controlled phase I PK bridging study to evaluate the PK, safety and tolerability of SR750 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SR750 tablet | Ascending single and multiple doses of SR750 orally |
| DRUG | Placebo | Ascending single and multiple doses of placebo orally |
Timeline
- Start date
- 2023-02-28
- Primary completion
- 2023-09-06
- Completion
- 2023-09-06
- First posted
- 2023-03-03
- Last updated
- 2024-11-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05753033. Inclusion in this directory is not an endorsement.